Table 1.
Clinical and laboratory characteristics of patient cohort treated for strongyloidiasis (n = 413)
| Characteristic | number | % |
|---|---|---|
| Median age in years (interquartile range) | 48 years (range 36–61 years) | |
| Female (n) | 158 | (38) |
| Migrant/traveler status known (n = 400) | ||
| Patients classified as migrants | 315/400 | (78.8) |
| Patients classified as travelers | 85/400 | (21.3) |
| Primary presenting symptoms (n = 405) | ||
| Gastrointestinal | 131 | (32.3) |
| Dermatological | 32 | (7.9) |
| Respiratory | 15 | (3.7) |
| Other | 38 | (9.4) |
| Asymptomatic | 189 | (46.7) |
| Underlying immunosuppression (n = 48) | ||
| Immunosuppressive medications including chemotherapy | 8 | (16.7) |
| Steroid use | 8 | (16.7) |
| HIV infection | 12 | (25) |
| HTLV-1 infection | 7 | (14.6) |
| Other | 13 | (27.1) |
| Positive Strongyloides microscopy/culture (n = 86) | ||
| Positive on stool microscopy alone | 42/86 | (48.8) |
| Positive on charcoal culture alone | 29/86 | (33.7) |
| Positive on both stool microscopy and charcoal culture | 15/86 | (17.4) |
| Overall sensitivity of eosinophilia in cases confirmed by microscopy/culture | 59/77 | (76.6) |
| Sensitivity of eosinophilia in migrants | 46/60 | (76.7) |
| Sensitivity of eosinophilia in travelers | 10/13 | (76.9) |
| Overall sensitivity of serology in cases confirmed by microscopy/culture | 70/86 | (81) |
| Sensitivity of serology in migrants | 61/68 | (89.7) |
| Sensitivity of serology in travelers | 6/13 | (42.2) |